Literature DB >> 11590631

Within-subject exposure dependency in case-crossover studies.

S K Vines1, C P Farrington.   

Abstract

In the case-crossover design, only cases are sampled and the hazard ratio is estimated from within-subject comparisons of exposures at the event time and in M control periods prior to the event. We consider the effect of within-subject dependence of exposures in successive time periods. We show that estimates obtained from the conditional logistic model are biased. This bias disappears if the distribution of exposures in the M+1 successive time intervals is exchangeable. In contrast, the Mantel-Haenszel estimator for the odds ratio is approximately unbiased provided that exposures are stationary. Suitable methods of analysis of case-crossover designs using maximum likelihood may be derived from cohort rather than case-control models. Copyright 2001 John Wiley & Sons, Ltd.

Mesh:

Year:  2001        PMID: 11590631     DOI: 10.1002/sim.960

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  13 in total

Review 1.  Developments in post-marketing comparative effectiveness research.

Authors:  S Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2007-06-06       Impact factor: 6.875

2.  Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection.

Authors:  Zachary Burningham; Tao He; Chia-Chen Teng; Xi Zhou; Jonathan Nebeker; Brian C Sauer
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

3.  Work related stressful life events and the risk of myocardial infarction. Case-control and case-crossover analyses within the Stockholm heart epidemiology programme (SHEEP).

Authors:  Jette Möller; Töres Theorell; Ulf de Faire; Anders Ahlbom; Johan Hallqvist
Journal:  J Epidemiol Community Health       Date:  2005-01       Impact factor: 3.710

4.  "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.

Authors:  Shirley V Wang; Sebastian Schneeweiss; Malcolm Maclure; Joshua J Gagne
Journal:  Am J Epidemiol       Date:  2014-08-01       Impact factor: 4.897

5.  Exchangeability in the case-crossover design.

Authors:  Murray A Mittleman; Elizabeth Mostofsky
Journal:  Int J Epidemiol       Date:  2014-04-22       Impact factor: 7.196

Review 6.  A systematic review and meta-analysis of alcohol consumption and injury risk as a function of study design and recall period.

Authors:  Cornelia Zeisser; Tim R Stockwell; Tanya Chikritzhs; Cheryl Cherpitel; Yu Ye; Christian Gardner
Journal:  Alcohol Clin Exp Res       Date:  2012-08-30       Impact factor: 3.455

7.  Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.

Authors:  Francesco Lapi; Claudia Pozzi; Giampiero Mazzaglia; Andrea Ungar; Stefano Fumagalli; Niccolò Marchionni; Pierangelo Geppetti; Alessandro Mugelli; Mauro Di Bari
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Bias in case-crossover studies of medications due to persistent use: A simulation study.

Authors:  Katsiaryna Bykov; Shirley V Wang; Jesper Hallas; Anton Pottegård; Malcolm Maclure; Joshua J Gagne
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-06-16       Impact factor: 2.890

Review 9.  Case-only designs in pharmacoepidemiology: a systematic review.

Authors:  Sandra Nordmann; Lucie Biard; Philippe Ravaud; Marina Esposito-Farèse; Florence Tubach
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

10.  Methodological framework to identify possible adverse drug reactions using population-based administrative data.

Authors:  Brian Sauer; Jonathan Nebeker; Shuying Shen; Randall Rupper; Suzanne West; Judith A Shinogle; Wu Xu; Kathleen N Lohr; Matthew Samore
Journal:  F1000Res       Date:  2014-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.